180 related articles for article (PubMed ID: 8866423)
1. Enhanced superoxide dismutase-2 immunoreactivity of astrocytes and occasional neurons in amyotrophic lateral sclerosis.
Blaauwgeers HG; Vianney de Jong JM; Verspaget HW; van den Berg FM; Troost D
J Neurol Sci; 1996 Sep; 140(1-2):21-9. PubMed ID: 8866423
[TBL] [Abstract][Full Text] [Related]
2. Motor neuron-astrocyte interactions and levels of Cu,Zn superoxide dismutase in sporadic amyotrophic lateral sclerosis.
O'Reilly SA; Roedica J; Nagy D; Hallewell RA; Alderson K; Marklund SL; Kuby J; Kushner PD
Exp Neurol; 1995 Feb; 131(2):203-10. PubMed ID: 7895821
[TBL] [Abstract][Full Text] [Related]
3. Expression of hepatocyte growth factor and c-Met in the anterior horn cells of the spinal cord in the patients with amyotrophic lateral sclerosis (ALS): immunohistochemical studies on sporadic ALS and familial ALS with superoxide dismutase 1 gene mutation.
Kato S; Funakoshi H; Nakamura T; Kato M; Nakano I; Hirano A; Ohama E
Acta Neuropathol; 2003 Aug; 106(2):112-20. PubMed ID: 12707786
[TBL] [Abstract][Full Text] [Related]
4. Metabolic dysfunction in familial, but not sporadic, amyotrophic lateral sclerosis.
Browne SE; Bowling AC; Baik MJ; Gurney M; Brown RH; Beal MF
J Neurochem; 1998 Jul; 71(1):281-7. PubMed ID: 9648876
[TBL] [Abstract][Full Text] [Related]
5. Decrease in Cu/Zn- and Mn-superoxide dismutase activities in brain and spinal cord of patients with amyotrophic lateral sclerosis.
Uchino M; Ando Y; Tanaka Y; Nakamura T; Uyama E; Mita S; Murakami T; Ando M
J Neurol Sci; 1994 Dec; 127(1):61-7. PubMed ID: 7699393
[TBL] [Abstract][Full Text] [Related]
6. PARP expression is increased in astrocytes but decreased in motor neurons in the spinal cord of sporadic ALS patients.
Kim SH; Henkel JS; Beers DR; Sengun IS; Simpson EP; Goodman JC; Engelhardt JI; Siklós L; Appel SH
J Neuropathol Exp Neurol; 2003 Jan; 62(1):88-103. PubMed ID: 12528821
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of neuronal nitric oxide synthase spliced variants in reactive astrocytes of amyotrophic lateral sclerosis human spinal cord.
Catania MV; Aronica E; Yankaya B; Troost D
J Neurosci; 2001 Jun; 21(11):RC148. PubMed ID: 11344254
[TBL] [Abstract][Full Text] [Related]
8. Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis.
Bowling AC; Schulz JB; Brown RH; Beal MF
J Neurochem; 1993 Dec; 61(6):2322-5. PubMed ID: 8245985
[TBL] [Abstract][Full Text] [Related]
9. Astrogliosis in ALS: possible interpretations according to pathogenetic hypotheses.
Schiffer D; Fiano V
Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Mar; 5(1):22-5. PubMed ID: 15204020
[TBL] [Abstract][Full Text] [Related]
10. TDP-43 immunoreactivity in neuronal inclusions in familial amyotrophic lateral sclerosis with or without SOD1 gene mutation.
Tan CF; Eguchi H; Tagawa A; Onodera O; Iwasaki T; Tsujino A; Nishizawa M; Kakita A; Takahashi H
Acta Neuropathol; 2007 May; 113(5):535-42. PubMed ID: 17333220
[TBL] [Abstract][Full Text] [Related]
11. Astrocyte loss of mutant SOD1 delays ALS disease onset and progression in G85R transgenic mice.
Wang L; Gutmann DH; Roos RP
Hum Mol Genet; 2011 Jan; 20(2):286-93. PubMed ID: 20962037
[TBL] [Abstract][Full Text] [Related]
12. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
[TBL] [Abstract][Full Text] [Related]
13. Increased Expression of 15-Hydroxyprostaglandin Dehydrogenase in Spinal Astrocytes During Disease Progression in a Model of Amyotrophic Lateral Sclerosis.
Miyagishi H; Kosuge Y; Takano A; Endo M; Nango H; Yamagata-Murayama S; Hirose D; Kano R; Tanaka Y; Ishige K; Ito Y
Cell Mol Neurobiol; 2017 Apr; 37(3):445-452. PubMed ID: 27140190
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in research on neuropathological aspects of familial amyotrophic lateral sclerosis with superoxide dismutase 1 gene mutations: neuronal Lewy body-like hyaline inclusions and astrocytic hyaline inclusions.
Kato S; Saito M; Hirano A; Ohama E
Histol Histopathol; 1999 Jul; 14(3):973-89. PubMed ID: 10425565
[TBL] [Abstract][Full Text] [Related]
15. Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis.
Ferrante RJ; Browne SE; Shinobu LA; Bowling AC; Baik MJ; MacGarvey U; Kowall NW; Brown RH; Beal MF
J Neurochem; 1997 Nov; 69(5):2064-74. PubMed ID: 9349552
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylated Smad2/3 immunoreactivity in sporadic and familial amyotrophic lateral sclerosis and its mouse model.
Nakamura M; Ito H; Wate R; Nakano S; Hirano A; Kusaka H
Acta Neuropathol; 2008 Mar; 115(3):327-34. PubMed ID: 18210139
[TBL] [Abstract][Full Text] [Related]
17. Cu/Zn superoxide dismutase activity at different ages in sporadic amyotrophic lateral sclerosis.
Fiszman ML; Borodinsky LN; Ricart KC; Sanz OP; Sica RE
J Neurol Sci; 1999 Jan; 162(1):34-7. PubMed ID: 10064166
[TBL] [Abstract][Full Text] [Related]
18. HtrA2/Omi-immunoreactive intraneuronal inclusions in the anterior horn of patients with sporadic and Cu/Zn superoxide dismutase (SOD1) mutant amyotrophic lateral sclerosis.
Kawamoto Y; Ito H; Kobayashi Y; Suzuki Y; Akiguchi I; Fujimura H; Sakoda S; Kusaka H; Hirano A; Takahashi R
Neuropathol Appl Neurobiol; 2010 Jun; 36(4):331-44. PubMed ID: 20202124
[TBL] [Abstract][Full Text] [Related]
19. S100A6 overexpression within astrocytes associated with impaired axons from both ALS mouse model and human patients.
Hoyaux D; Boom A; Van den Bosch L; Belot N; Martin JJ; Heizmann CW; Kiss R; Pochet R
J Neuropathol Exp Neurol; 2002 Aug; 61(8):736-44. PubMed ID: 12152788
[TBL] [Abstract][Full Text] [Related]
20. Alterations in anti-oxidative defence enzymes in erythrocytes from sporadic amyotrophic lateral sclerosis (SALS) and familial ALS patients.
Nikolić-Kokić A; Stević Z; Blagojević D; Davidović B; Jones DR; Spasić MB
Clin Chem Lab Med; 2006; 44(5):589-93. PubMed ID: 16681429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
